An Anti-HIV-1 V3 Loop Antibody Fully Protects Cross-Clade and Elicits T-Cell Immunity in Macaques Mucosally Challenged with an R5 Clade C SHIV-Reference-Cited by-同舟云学术

An Anti-HIV-1 V3 Loop Antibody Fully Protects Cross-Clade and Elicits T-Cell Immunity in Macaques Mucosally Challenged with an R5 Clade C SHIV

Published:2011-03-31 Issue:3 Volume:6 Page:e18207
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Watkins Jennifer D.,Siddappa Nagadenahalli B.,Lakhashe Samir K.,Humbert Michael,Sholukh Anton,Hemashettar Girish,Wong Yin Ling,Yoon John K.,Wang Wendy,Novembre Francis J.,Villinger Francois,Ibegbu Chris,Patel Kalpana,Corti Davide,Agatic Gloria,Vanzetta Fabrizia,Bianchi Siro,Heeney Jonathan L.,Sallusto Federica,Lanzavecchia Antonio,Ruprecht Ruth M.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference26 articles.

1. Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.;JR Mascola;J Infect Dis,1996

2. Placebo controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.;NM Flynn;J Infect Dis,2005

3. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.;P Pitisuttithum;J Infect Dis,2006

4. Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.;JR Mascola;J Virol,1999

5. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection.;TW Baba;Nat Med,2000

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PET/CT Targeted Tissue Sampling Reveals Intravenously Administered HGN194 IgG1 Affects HIV Distribution after Rectal Exposure;AIDS Research and Human Retroviruses;2024-08-28

2. B cell repertoire sequencing of HIV-1 pediatric elite-neutralizers identifies multiple broadly neutralizing antibody clonotypes;Frontiers in Immunology;2024-02-16

3. B cell repertoire sequencing of HIV-1 pediatric elite-neutralizers identifies multiple broadly neutralizing antibody clonotypes;2023-07-07

4. Vaccinal effect of HIV-1 antibody therapy: dream or reality?;Current Opinion in HIV and AIDS;2023-05-03

5. Challenges and opportunities in gene editing of B cells;Biochemical Pharmacology;2022-12